Sign In

Login

Password

Forgot Password ? Sign Up

Atorvastatin (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Atorvastatin" in German language version.

refsWebsite
Global rank German rank
5doi.org
2nd place
3rd place
3web.archive.org
1st place
1st place
2nih.gov
4th place
7th place
1drugbank.ca
4,294th place
2,006th place
1sigmaaldrich.com
924th place
87th place
1oxfordjournals.org
1,389th place
859th place
1medlineplus.gov
1,581st place
low place
1redirecter.toolforge.org
33rd place
2nd place
1cnn.com
28th place
91st place
1deutsche-apotheker-zeitung.de
low place
797th place
1statista.com
776th place
182nd place
1arzneimittel-atlas.de
low place
low place
1aerzteblatt.de
3,043rd place
200th place
1archive.today
14th place
31st place

aerzteblatt.de

archive.today

arzneimittel-atlas.de

cnn.com

money.cnn.com

deutsche-apotheker-zeitung.de

doi.org

  • V. M. Sonje, L. Kumar, V. Puri, G. Kohli, A. M. Kaushal, A. K. Bansal: Effect of counterions on the properties of amorphous atorvastatin salts. In: Eur J Pharm Sci. 44 (2011) S. 462–470, doi:10.1016/j.ejps.2011.08.023.
  • Helen M Colhoun, D John Betteridge, Paul N Durrington, Graham A Hitman, H Andrew W Neil, Shona J Livingstone, Margaret J Thomason, Michael I Mackness, Valentine Charlton-Menys, John H Fuller: Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. In: The Lancet. Band 364, Nr. 9435, August 2004, S. 685–696, doi:10.1016/S0140-6736(04)16895-5.
  • N. Sattar et al.: Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. In: The Lancet. Band 375, Nr. 9716, 2010, S. 735–742, doi:10.1016/S0140-6736(09)61965-6.
  • B. Calo-Fernández, J. L. Martínez-Hurtado: Biosimilars: Company Strategies to Capture Value from the Biologics Market. Pharmaceuticals, Bd. 5, Nr. 12, 2012, S. 1393–1408. doi:10.3390/ph5121393
  • Fabian Weber, Gottfried Sedelmeier: 200 umsatzstarke Medikamente. In: Nachrichten aus der Chemie. Band 61, Nr. 5, Mai 2013, S. 528–529, doi:10.1002/nadc.201390162.

drugbank.ca

medlineplus.gov

nih.gov

ncbi.nlm.nih.gov

  • P. Jones et al.: Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Am J Cardiol. 1. März 1998; 81 (5): S. 582–587; PMID 9514454.
  • Anton F. H. Stalenhoef et al.: A Comparative study with rosuvastatin in subjects with Metabolic Syndrome: results of the COMETS study Eur Heart J. Dezember 2005;26 (24): S. 2664–2672 Volltext (HTML) Volltext (PDF; 264 kB), PMID 16143705.

oxfordjournals.org

eurheartj.oxfordjournals.org

redirecter.toolforge.org

  • HMGCoA reductase inhibitor (statin) drugs- Risk of immune-mediated necrotizing myopathy (IMNM) Label Changes. U.S. Food and Drug Administration, 1. Oktober 2012, archiviert vom Original am 3. März 2016; abgerufen am 3. Mai 2021 (englisch).

sigmaaldrich.com

statista.com

de.statista.com

  • Jahre 2011─2018: Arzneiverordnungs-Report. Jahre 2003─2010: Arzneimittel - Verbrauch von lipidsenkenden Mitteln in Deutschland 2003–2010. Veröffentlicht von Statista Research Department, 12. September 2012 [1].

web.archive.org